Conductive keratoplasty (CK) corrects mild-to-moderate hyperopia, but the results may not be permanent, according to Jason Erlich, MD, of Stanford University School of Medicine, USA.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.